TY  - JOUR
AU  - Miró Corrales, Guadalupe
AU  - Segarra, Sergi
AU  - Cerón, José Joaquín
AU  - Ferrer, Lluís
AU  - Solano Gallego, Laia
AU  - Montell, Laia
AU  - Costa, Ester
AU  - Teichenne, Joan
AU  - Mariné Casadó, Roger
AU  - Roura, Xavier
AU  - GALILEI Trial Group
PY  - 2024
SN  - 1935-2735
UR  - https://hdl.handle.net/20.500.14352/116307
T2  - Neglected Tropical Diseases
AB  - The current standard treatment for canine leishmaniosis (CanL), N-methylglucamine antimoniate (MGA) given with allopurinol, is not fully effective and may cause adverse effects and drug resistance. In vitro and in vivo studies have shown that...
LA  - eng
M2  - 1
PB  - PLoS
TI  - New immunomodulatory treatment protocol for canine leishmaniosis reduces parasitemia and proteinuria
TY  - journal article
VL  - 18
ER  -